- ￥2890
- LSM Bio
- 0.156-10ng/ml
- 0.078ng/ml
- 国产
- ELI-21503h
- 2025年07月12日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
50
- 供应商：
LSMBIO
- 检测范围：
0.156-10ng/ml
- 检测方法：
夹心法/竞争法
- 应用：
夹心法/竞争法ELISA体外定量检测人血清、血浆或其它相关生物液体中蛋白浓度
- 适应物种：
人
- 标记物：
Graves disease carrier protein,SLC25A16
- 样本：
人血清、血浆或其它相关生物液体中天然和重组蛋白
- 灵敏度：
0.078ng/ml
- 规格：
96T
Human Graves disease carrier protein, SLC25A16 ELISA KIT
Product Name:Human Graves disease carrier protein, SLC25A16 ELISA KIT
Packing:96T
Catalog No.:ELI-21503h
Gene Name:SLC25A16
Detect Range:78-5000 pg/mL
Sensitivity:32pg/mL
Target Protein Name:Graves disease carrier protein(SLC25A16
Alternative Name:SLC25A16,Graves disease carrier protein(SLC25A16
Sample type:serum, plasma, tissue homogenates, cell culture supernates or other biological fluids.
ELISA type:Sandwich ELISA Kit
Product Description:Human Graves disease carrier protein, SLC25A16 ELISA KIT allows for the in vitro quantitative determination of Graves disease carrier protein(SLC25A16 concentrations in serum, plasma, tissue homogenates, cell culture supernates or other biological fluids.
ELISA Test Principle:
The microtiter plate provided in Human Graves disease carrier protein, SLC25A16 ELISA KIT has been pre-coated with an Graves disease carrier protein(SLC25A16 antibody specific to Graves disease carrier protein(SLC25A16 .Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody preparation specific for Graves disease carrier protein(SLC25A16 and then avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then a TMB substrate solution is added to each well. Only those wells that contain Graves disease carrier protein(SLC25A16, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of a sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450 nm.The concentration of Graves disease carrier protein(SLC25A16 in the samples is then determined by comparing the O.D. of the samples to the standard curve.
NOTE:FOR RESEARCH USE ONLY; NOT FOR THERAPEUTIC OR DIAGNOSTIC APPLICATIONS! PLEASE READ ENTIRE PROCEDURE!
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验The determination of the protein content of urokinase-type plasminogen activator (uPA) and its inhibitor, PAI-1, in breast cancer tissue extracts is used clinically to identify patients at risk to experience disease recurrence (metastasis
Mapping and Ranking Motifs with Minimotif Miner Interpretation and Selecting Motifs Mapping Motifs onto Protein Surfaces Using Minimotif Miner to Investigate Disease
Disease and Phenotype Data at Ensembl
sciences community, which includes researchers focusing on human disease. Here we discuss the Ensembl genome browser, which acts as a single entry point with Graphical User Interface to data from multiple projects, including OMIM, dbSNP, and the NHGRI GWAS
技术资料暂无技术资料 索取技术资料
